River Vision Development
New York, New York, United States
About River Vision Development
River Vision Development develops RV001, a protein therapy for the treatment of Graves’ Orbitopathy (GO). River Vision Development was founded in 2011 and is based in New York, New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $33.3M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2016)
- Phone: +1 (212) 582-8400
Industries & Categories
Health Care, Therapeutics, Wellness
Canonical: https://fsome.com/organization/river-vision-development-2480546 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.